Clinical Evaluation of Urinary Transforming Growth Factor-Beta1 and Serum Alpha-Fetoprotein as Tumour Markers of Hepatocellular Carcinoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1997.250
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Serum Exosomal microRNAs Combined With Alpha-Fetoprotein as Diagnostic Markers of Hepatocellular Carcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2018English

Hepatocellular Carcinoma; Correlation of Serum Alpha Fetoprotein and Tumor Size

THE PROFESSIONAL MEDICAL JOURNAL
2016English

Serum Transforming Growth Factor Α in Liver Cirrhosis and Hepatocellular Carcinoma

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Transforming Growth Factor Beta1 and Aldosterone

Current Opinion in Nephrology and Hypertension
Internal MedicineNephrology
2015English

Evaluation of HCV-associated Hepatocellular Carcinoma Based on Alpha-Fetoprotein Levels

Afro-Egyptian Journal of Infectious and Endemic Diseases
2019English

IGF-I Production by Adult Rat Hepatocytes Is Stimulated by Transforming Growth Factor-Alpha and Transforming Growth Factor-Beta1

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Soluble CD25 as a Predictor of Hepatocellular Carcinoma Compared With Alpha-Fetoprotein

Clinical and Experimental Hepatology
Hepatology
2019English

Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?

Gastroenterology
HepatologyGastroenterology
2015English

Transforming Growth Factor Beta1 (TGFbeta1) in Physiology and Pathology

Endokrynologia Polska
EndocrinologyMetabolismDiabetes
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy